Know Cancer

or
forgot password


N/A
21 Years
64 Years
Not Enrolling
Female
Breast Cancer

Thank you

Trial Information


Inclusion Criteria:



1. Histologically confirmed stage I-III breast carcinoma

2. < 65 years old

3. Female

Exclusion Criteria:

1. Previous exposure to chemotherapy/anti-hormonal therapy for any other malignancy

2. Previous neoadjuvant therapy for breast cancer

3. Concomitant second primary in-situ or invasive carcinoma or previous history of
carcinoma/carcinoma-in-situ

4. Known disease or injury to the central nervous system (including neurodegenerative
diseases, epilepsy), severe visual or auditory disorders

5. Motor weakness due to any cause which makes using a touchscreen computer difficult

6. Known background of depression, anxiety disorders or other neurobehavioural
conditions

7. Ongoing use of tranquilisers or anti-depressants

8. Previous neuropsychological testing

9. Current or previous history of alcohol or drug dependent

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Examine the variation of cognitive function at various time-points in stage I-III breast cancer patients who have undergone or are undergoing adjuvant systemic therapy

Outcome Description:

To examine the variation of cognitive function at various time-points in stage I-III breast cancer patients who have undergone or are undergoing adjuvant systemic therapy (chemotherapy and/or anti-hormonal therapy) and compare this to a group of healthy controls to evaluate if there is a difference.

Authority:

Singapore: Domain Specific Review Boards

Study ID:

Version 01

NCT ID:

NCT01596439

Start Date:

June 2012

Completion Date:

Related Keywords:

  • Breast Cancer
  • Healthy women
  • consisting of a friend or relative of the patient
  • Breast Neoplasms

Name

Location